ArticleNature medicine2018

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.

Gabrielle S Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.